Oncology · Approved programs

Top sponsors

• First People's Hospital 19 programs
• Disc Medicine 18 programs
• Chinese Academy of 16 programs
• George Institute for 8 programs
• Novartis India 6 programs
• Takeda 6 programs
• HOFFMANN-LA ROCHE 4 programs
• Telethon Foundation 4 programs
• Pfizer 3 programs
• AstraZeneca 2 programs
• Eli Lilly and 2 programs
• First Biotech (Australia) 2 programs

1. 2024/3873 CABOLD

   The George Institute

   Renal carcinoma

   approved · small molecule · active

   1 trial →

2. 20510

   Bayer AG

   metastatic castrate resistant prostate cancer (mCRPC)

   approved · small molecule · active

   1 trial →

3. 22590

   Disc Medicine

   Metastatic cervical cancer

   approved · small molecule · active

   1 trial →

4. 99mTc-Macro Albumin Aggregate

   BRIGHT MINDS BIOSCIENCES INC.

   Carcinoma

   approved · small molecule · completed

   1 trial →

5. ATRA+Arsenic

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Acute Promyelocytic Leukemia

   approved · small molecule · active

   1 trial →

6. Abemaciclib

   Eli Lilly and Company

   Breast Neoplasms

   approved · small molecule · completed

   1 trial →

7. Abemaciclib

   Eli Lilly and Company

   Metastatic Breast Cancer

   approved · small molecule · terminated

   1 trial →

8. Academic Detailing

   United Therapeutics Europe Ltd

   Prostate Cancer

   approved · other · terminated

   1 trial →

9. Afatinib

   Boehringer Ingelheim

   Carcinoma, Non-Small-Cell Lung

   approved · small molecule · completed

   1 trial →

10. Alecensa 150 mg hard capsules

    Disc Medicine

    ALK positive non-small cell lung cancer

    approved · small molecule · active

    1 trial →

11. Atezolizumab

    Hoffmann-La Roche

    Carcinoma, Non-Small-Cell Lung

    approved · small molecule · completed

    1 trial →

12. Babaodan oral capsule

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    approved · small molecule · active

    1 trial →

13. Bavencio 20 mg/mL concentrate for solution for infusion

    Disc Medicine

    urothelial cancer, Bladder cancer, muscle invasive bladder cancer

    approved · small molecule · active

    1 trial →

14. Blinatumomab

    The First People's Hospital of Lianyungang

    Acute B-cell Lymphoblastic Leukemia

    approved · small molecule · active

    1 trial →

15. Brentuximab vedotin

    Takeda

    T-Cell Lymphoma

    approved · small molecule · completed

    1 trial →

16. Brentuximab vedotin

    Takeda

    Lymphoma

    approved · small molecule · active

    2 trials →

17. Brucea javanica oil emulsion injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved · other · active

    1 trial →

18. C4221026

    Pfizer Australia Pty Ltd

    Solid tumors

    approved · small molecule · active

    1 trial →

19. CDRB436G2401

    Novartis Pharmaceuticals

    Children and Adolescents with Cancers Harboring V600 mutation.

    approved · small molecule · active

    1 trial →

20. CERITINIB

    Novartis Pharmaceuticals

    non small cell lung cancer

    approved · small molecule · active

    1 trial →

21. CLEAN+

    The George Institute

    colorectal cancer early detection

    approved · small molecule · active

    1 trial →

22. CLEE011A2412B

    Novartis Pharmaceuticals

    HR+, HER2- advanced or metastatic breast cancer

    approved · small molecule · active

    1 trial →

23. CML1415 - Sustrenim

    Fondazione Telethon ETS

    Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)

    approved · small molecule · active

    1 trial →

24. CO2MO

    Disc Medicine

    Melanoma

    approved · small molecule · active

    1 trial →

25. COBICISTAT , OLAPARIB

    Disc Medicine

    Cancer

    approved · small molecule · active

    1 trial →

26. Camrelizumab + chemotherapy+Thalidomide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    approved · small molecule · active

    1 trial →

27. Chemoembolization and Response-Dependent Resection

    The First People's Hospital of Lianyungang

    Resectable Hepatocellular Carcinoma Beyond Milan Criteria

    approved · other · active

    1 trial →

28. Chlorhexidine gluconate

    Hospital Authority, Hong Kong

    Liver Tumors

    approved · small molecule · completed

    1 trial →

29. Cinobufacini injection

    The First People's Hospital of Lianyungang

    Liver Cancer

    approved · small molecule · active

    1 trial →

30. Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie

    Disc Medicine

    Locally advanced head and neck squamous cell carcinoma

    approved · small molecule · active

    1 trial →

31. Cytokine-induced killer cells+ FOLFOX4

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved · small molecule · completed

    1 trial →

32. D9311L00001

    AstraZeneca

    Advanced or recurrent endometrial cancer

    approved · small molecule · active

    1 trial →

33. DOTAREM for Breast Cancer

    Disc Medicine

    Breast Cancer

    approved · small molecule · active

    1 trial →

34. DS-8201a

    AstraZeneca AB

    Treatment of patients with HER2-positive breast cancer with or without brain metastasis

    approved · small molecule · active

    1 trial →

35. Dexamethasone

    The First People's Hospital of Lianyungang

    Pancreatic Cancer

    approved · small molecule · active

    1 trial →

36. Dexamethasone

    The First People's Hospital of Lianyungang

    Carcinoma, Non-Small-Cell Lung

    approved · small molecule · terminated

    1 trial →

37. Dexamethasone tablets for Solid tumors

    Disc Medicine

    Solid tumors

    approved · small molecule · active

    1 trial →

38. Dexmedetomidine

    United Therapeutics Europe Ltd

    Breast Cancer

    approved · small molecule · active

    1 trial →

39. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved · small molecule · completed

    1 trial →

40. Dexmedetomidine

    Peking University Third Hospital

    Breast Cancer

    approved · small molecule · completed

    1 trial →

41. Dexmedetomidine Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    approved · small molecule · completed

    1 trial →

42. Dotarem®

    Guerbet

    Primary Brain Tumor

    approved · small molecule · completed

    1 trial →

43. Durvalumab

    AstraZeneca

    Solid Tumor

    approved · small molecule · completed

    1 trial →

44. EC-120888

    CERO THERAPEUTICS HOLDINGS, INC.

    Completely resected stage I or IIA non-squamous non-small cell lung cancer (NSCLC)

    approved · small molecule · active

    1 trial →

45. EC/2013/472

    Takeda

    Prostate or Bladder Cancer

    approved · small molecule · completed

    1 trial →

46. Enhanced dermatologic management

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC (Advanced Non-small Cell Lung Cancer)

    approved · other · active

    1 trial →

47. Epirubicin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Hepatocellular

    approved · small molecule · active

    1 trial →

48. Etoposide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mantle Cell Lymphoma

    approved · small molecule · completed

    1 trial →

Frequently asked questions